Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
43
datasets available to search
ShareScore release 0.9.0
Dataset results
43 results for “psilocybin therapy”
Psilocybin therapy for females with anorexia nervosa: A phase 1, open label, feasibility study
<p class="MsoNoSpacing">Anorexia nervosa (AN) is a deadly illness with no proven treatments to reverse core symptoms and no FDA-approved medications. Novel treatments are urgently needed to improve clinical outcomes. In this open-label feasibility study, 10 adult female participants (<em>m</em> BMI 19.7 kg/m<sup>2</sup>; SD 3.7) who met DSM 5 criteria for AN or pAN (partial remission) were recruited to a study conducted at an academic clinical research institute. Participants received a single 25mg dose of synthetic psilocybin combined with psychological support. The primary aim was to assess safety, tolerability, and feasibility at post-treatment via incidences and occurrences of adverse events (AEs) and clinically significant changes in: ECG, laboratory tests, vital signs and suicidality. There were no clinically significant changes in ECG, vital signs, or suicidality. Two participants developed asymptomatic hypoglycemia at post-treatment, which resolved within 24 hours. There were no other clinically significant changes in laboratory values. All AEs were mild and transient in nature. Participants' qualitative perceptions suggest that the treatment was acceptable for most participants. <span>R</span>esults suggest that psilocybin therapy is safe, tolerable, and acceptable for female AN, a promising finding given physiological dangers and problems with treatment engagement.</p> <p class="MsoNoSpacing">ClinicalTrials.gov Identifier: NCT04661514</p>
Psilocybin-Assisted Therapy for the Treatment of Cancer-Related Anxiety in Patients With Metastatic Cancer
ClinicalTrials.gov study NCT05847686. IPD Sharing: NO. Countries: 1. Publications: 1.
Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS Survivors
ClinicalTrials.gov study NCT02950467. IPD Sharing: NO. Countries: 1. Publications: 1.
Psilocybin-Assisted Therapy in Treatment-Resistant Depression
ClinicalTrials.gov study NCT06303739. IPD Sharing: YES. Countries: 1. Publications: 15.
Psilocybin therapy for females with anorexia nervosa: A phase 1, open label, feasibility study
Open the record for dataset details and reuse information.
Psilocybin Therapy for Depression and Anxiety in Parkinson's Disease
ClinicalTrials.gov study NCT04932434. IPD Sharing: NO. Countries: 1. Publications: 7.
Pilot Trial of Visual Healing® in Psilocybin-assisted Therapy for Alcohol Use Disorder
ClinicalTrials.gov study NCT04410913. IPD Sharing: Not stated. Countries: 1. Publications: 11.
Psilocybin-assisted Interpersonal Therapy for Depression
ClinicalTrials.gov study NCT05581797. IPD Sharing: NO. Countries: 1. Publications: 1.
Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Caregivers of Patients With Advanced Cancer
ClinicalTrials.gov study NCT07048743. IPD Sharing: NO. Countries: 1. Publications: 18.
Psilocybin-assisted Therapy for Treatment of Alcohol Use Disorder
ClinicalTrials.gov study NCT05416229. IPD Sharing: YES. Countries: 1. Publications: 1.
Pragmatic Trial of Psilocybin Therapy in Palliative Care
ClinicalTrials.gov study NCT05403086. IPD Sharing: YES. Countries: 1. Publications: 11.
Psilocybin-Assisted Cognitive Processing Therapy for Chronic PTSD
ClinicalTrials.gov study NCT06386003. IPD Sharing: NO. Countries: 1. Publications: 1.
Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice Care
ClinicalTrials.gov study NCT04950608. IPD Sharing: YES. Countries: 1. Publications: 0.
Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder
ClinicalTrials.gov study NCT06160232. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Psilocybin Therapy in Advanced Cancer
ClinicalTrials.gov study NCT05398484. IPD Sharing: YES. Countries: 1. Publications: 1.
Psilocybin Therapy for Depression in Bipolar II Disorder
ClinicalTrials.gov study NCT05065294. IPD Sharing: NO. Countries: 1. Publications: 5.
Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer
ClinicalTrials.gov study NCT06416085. IPD Sharing: Not stated. Countries: 1. Publications: 16.
Psilocybin-Assisted Physical Therapy in Chronic Low Back Pain
ClinicalTrials.gov study NCT07306364. IPD Sharing: NO. Countries: 1. Publications: 9.
Effect of Psilocybin Only and Psilocybin Assisted Cognitive Behavioral Therapy in the Management of Major Depressive Disorder and Associated Metabolic, Immune, Inflammatory, Neuroplasticity and Electr
ClinicalTrials.gov study NCT06746441. IPD Sharing: YES. Countries: 1. Publications: 5.
The Safety and Efficacy Of Psilocybin as an Adjunctive Therapy in Participants With Treatment Resistant Depression
ClinicalTrials.gov study NCT04739865. IPD Sharing: Not stated. Countries: 2. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.